Evidence map›Paper›PMID 27195907›Full record

ArticleHuman pathology2016

Myoepithelial cells in lobular carcinoma in situ: distribution and immunophenotype.

Ying Wang, Sonali Jindal, Maritza Martel, Yaping Wu, Pepper Schedin, Megan Troxell

Abstract read
In one paragraph

Article in Human pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Solid papillary carcinoma of the breast.Autopsy & case reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ying WangDepartment of Pathology, Oregon Health & Science University, Portland, OR 97239.
Sonali JindalDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239.
Maritza MartelDepartment of Pathology, Providence Health and Services, Portland, OR 97213.
Yaping WuDepartment of Pathology, Providence Health and Services, Portland, OR 97213.
Pepper SchedinDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239; Oregon Health & Science University, Knight Cancer Institute, Portland, OR 97239.
Megan TroxellDepartment of Pathology, Oregon Health & Science University, Portland, OR 97239; Oregon Health & Science University, Knight Cancer Institute, Portland, OR 97239. Electronic address: megant@stanford.edu.
Oregon Health & Science University · USProvidence Health & Services · US

Funding

NSAIDs During Postpartum Involution for Breast Cancer ChemopreventionR01CA169175 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHEDIN, PEPPER J · 2013 to 2024
$4.8M
NCI NIH HHS R01 CA169175
6 · The paper itself

Abstract

Myoepithelial cells have important physical and paracrine roles in breast tissue development, maintenance, and tumor suppression. Recent molecular and immunohistochemical studies have demonstrated phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells. Although the relationship of lobular carcinoma in situ (LCIS) and myoepithelial cells was described in 1980, further characterization of LCIS-associated myoepithelial cells is lacking. We stained 27 breast specimens harboring abundant LCIS with antibodies to smooth muscle myosin heavy chain, smooth muscle actin, and calponin. Dual stains for E-cadherin/smooth muscle myosin heavy chain and CK7/p63 were also performed. In each case, the intensity and distribution of staining in LCIS-associated myoepithelial cells were compared with normal breast tissue on the same slide. In 78% of the cases, LCIS-associated myoepithelial cells demonstrated decreased staining intensity for one or more myoepithelial markers. The normal localization of myoepithelial cells (flat against the basement membrane, pattern N) was seen in 96% of LCIS, yet 85% of cases had areas with myoepithelial cell cytoplasm oriented perpendicular to the basement membrane (pattern P), and in 30% of cases, myoepithelial cells appeared focally admixed with LCIS cells (pattern C). This study characterizes detailed architectural and immunophenotypic alterations of LCIS-associated myoepithelial cells. The finding of variably diminished staining favors application of several myoepithelial immunostains in clinical practice. The interaction of LCIS with myoepithelial cells, especially in light of the perpendicular and central architectural arrangements, deserves further mechanistic investigation.

Indexed as

ImmunohistochemistryActinsBiomarkers, TumorBreast Carcinoma In SituBreast NeoplasmsCalcium-Binding ProteinsCalponinsEpithelial CellsFemaleHumansImmunophenotypingKeratin-7Microfilament ProteinsMyosin Heavy ChainsPhenotypePredictive Value of TestsACTA2 protein, humanActinsBiomarkers, TumorCalcium-Binding ProteinsCalponinsKeratin-7KRT7 protein, humanMicrofilament ProteinsMYH11 protein, humanMyosin Heavy ChainsTP63 protein, humanTranscription FactorsTumor Suppressor ProteinsCalponinImmunohistochemistry p63Lobular carcinoma in situ (LCIS)Myoepithelial cellSmooth muscle actinSmooth muscle myosin heavy chain

Identifiers

PMID27195907
PMCPMC13590029
OpenAlexW2403447941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.